Haleon (HLN) Total Non-Current Liabilities (2021 - 2025)

Haleon (HLN) posted Total Non-Current Liabilities of $14.9 billion for Q4 2025, down 5.36% on a QoQ basis from $15.8 billion in Q4 2024, and down 5.36% year-over-year from $15.8 billion in Q4 2024.

Haleon (HLN) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Haleon's Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $14.9 billion for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 5.36% year-over-year to $14.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.9 billion (down 5.36% YoY) and the FY2025 annual result came in at $14.8 billion, down 5.81% from the prior year.
  • Total Non-Current Liabilities was $14.9 billion for Q4 2025 at Haleon, down from $15.8 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $16.4 billion in Q4 2022 and bottomed at -$17.4 billion in Q2 2022.
  • A 5-year average of $2.6 billion and a median of $10.0 billion in 2021 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 226.04% — and 2025, when it fell 5.36%.
  • Haleon's Total Non-Current Liabilities stood at $5.0 billion in 2021, then surged by 226.04% to $16.4 billion in 2022, then retreated by 4.03% to $15.7 billion in 2023, then increased by 0.09% to $15.8 billion in 2024, then decreased by 5.36% to $14.9 billion in 2025.
  • Business Quant data shows HLN's Total Non-Current Liabilities at $14.9 billion in Q4 2025, $15.8 billion in Q4 2024, and -$14.0 billion in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 604.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.92 Bn
Dec 31, 2024 15.76 Bn
Jun 30, 2024 -13.97 Bn
Dec 31, 2023 15.75 Bn
Jun 30, 2023 -15.78 Bn
Dec 31, 2022 16.41 Bn
Jun 30, 2022 -17.39 Bn
Dec 31, 2021 5.03 Bn